Search Result

Results for "

α-glucosidases

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Aldose Reductase (2) AMPK (1) Amylases (51) Amyloid-β (1) Anaplastic lymphoma kinase (ALK) (1) Angiotensin-converting Enzyme (ACE) (2) Antibiotic (5) Apoptosis (12) Aryl Hydrocarbon Receptor (3) Aurora Kinase (1) Bacterial (11) Bcl-2 Family (2) Biochemical Assay Reagents (2) c-Kit (1) Carbonic Anhydrase (2) Cholinesterase (ChE) (10) COX (3) Cytochrome P450 (1) Dengue Virus (4) Dipeptidyl Peptidase (8) DNA Alkylator/Crosslinker (1) DNA/RNA Synthesis (1) Drug Derivative (2) Drug Intermediate (2) Drug Metabolite (1) Endogenous Metabolite (27) Enterovirus (1) Environmental Pollutants (5) Estrogen Receptor/ERR (4) Fatty Acid Synthase (FASN) (2) Flavivirus (5) Fluorescent Dye (1) Fungal (4) Glucokinase (2) GLUT (3) Glutaminase (1) Glutathione Peroxidase (2) Glycosidase (359) HBV (2) HCV (2) HDAC (1) Heme Oxygenase (HO) (2) HIV (5) HIV Protease (1) HMG-CoA Reductase (HMGCR) (4) HSP (2) Influenza Virus (2) Interleukin Related (1) Isotope-Labeled Compounds (6) JAK (1) JNK (1) LDLR (2) Lipase (3) Lipoxygenase (1) MMP (1) Monoamine Oxidase (3) Mucin (1) NF-κB (6) NO Synthase (1) NOD-like Receptor (NLR) (3) Notch (1) P-glycoprotein (1) P2Y Receptor (1) p38 MAPK (2) Parasite (7) Phosphatase (9) Phosphodiesterase (PDE) (2) Phospholipase (1) PI3K (3) PKC (1) PPAR (6) Pregnane X Receptor (PXR) (2) Pyroptosis (2) Reactive Oxygen Species (ROS) (8) Reference Standards (29) SARS-CoV (2) STAT (1) TGF-beta/Smad (1) TGF-β Receptor (1) TNF Receptor (1) Toll-like Receptor (TLR) (1) Tyrosinase (7) VEGFR (1) α-synuclein (2) β-glucuronidase (1)
By Research Areas:	Cancer (49) Cardiovascular Disease (10) Endocrinology (8) Infection (56) Inflammation/Immunology (50) Metabolic Disease (295) Neurological Disease (21)
Click Chemistry:	Azide (1)
Oligonucleotides:	Sweetening Agents (1)

399

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

172

Natural
Products

Isotope-Labeled Compounds

Click Chemistry

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-B0481

Miglitol 2 Publications Verification BAY1099; BAY-m1099	Glycosidase AMPK Reactive Oxygen Species (ROS)	Metabolic Disease
Miglitol (BAY-m1099) is an orally active antidiabetic compound that inhibits the breakdown of glycoconjugates into glucose. Miglitol inhibits glycoside hydrolase enzymes called *α-glucosidases*. Miglitol inhibits oxidative stress-induced apoptosis and mitochondrial ROS over-production in endothelial cells by enhancement of AMP-activated protein kinase. Dietary supplementation with Miglitol from pre-onset stage in OLETF rats delays the onset and development of diabetes and preserves the insulin secretory function of pancreatic islets .

HY-113585

1,4-Dideoxy-1,4-imino-D-arabinitol hydrochloride	Endogenous Metabolite	Others
1,4-Dideoxy-1,4-imino-D-arabinitol hydrochloride is a naturally occurring pyrrolidine alkaloid that acts as an inhibitor of glycogen phosphorylase and α-glucosidases, and is sourced from Arachniodes standishii and Angylocalyx boutiqueanus.

HY-124662

IHVR-19029	Flavivirus Dengue Virus Glycosidase	Infection
IHVR-19029 is a potent endoplasmic reticulum (ER) α-glucosidases I and II inhibitor, with an IC₅₀ of 0.48 μM for ER a-glucosidase I. IHVR-19029 efficiently blocks the replication of several hemorrhagic fever viruses, such as Dengue virus (DENV), Ebola virus (EBOV) and Rift Valley fever virus. The combination of IHVR-19029 with Favipiravir (HY-14768) improves the antiviral efficacy .

HY-150560

α-Glucosidase-IN-11	Glycosidase	Metabolic Disease
α-Glucosidase-IN-11 is a highly permeable competitive *α-glucosidase* inhibitor with the IC₅₀ value of 0.56 μM. α-Glucosidase-IN-11 binds to Trp residues in α-glucosidase and regulates protein folding. α-Glucosidase-IN-11 can be used to regulate blood glucose levels .

HY-117721

IHVR-11029	Glucokinase	Infection Inflammation/Immunology
IHVR-11029 is a small molecule inhibitor of ER α-glucosidases, with an EC₅₀ of 0.09 μM .

HY-179141

*α-Amylase/α-Glucosidase-IN-23*	Amylases Glycosidase	Metabolic Disease
α-Amylase/α-Glucosidase-IN-23 (Compound 5e) is a *α-Amylase/α-Glucosidase* inhibitor with IC₅₀ values of 73.68 nM for α-glucosidase and 146.18 nM for α-amylase. α-Amylase/α-Glucosidase-IN-23 can be used in the research of hypoglycemia .

HY-P2802D

*exo-α-Glucosidase, Bacteroides thetaiotaomicron*	Glycosidase	Others
exo-α-Glucosidase,Bacteroides thetaiotaomicron (EC.3.2.1.20) is a α-Glucosidase. exo-α-Glucosidase, using maltose as a donor, exhibits excellent transglycosidic activity towards various receptors .

HY-152158

α-Glucosidase-IN-22	Glycosidase	Metabolic Disease
α-Glucosidase-IN-22 (Compound 7i) is a *α-glucosidase* inhibitor with an IC₅₀ value of 0.64 μM. α-Glucosidase-IN-22 can be used for the research of type 2 diabetes .

HY-179511

α-Glucosidase-IN-104	Glycosidase	Metabolic Disease
α-Glucosidase-IN-104 (Compound 9s) is an efficient inhibitor of *α-glucosidase* with an IC₅₀ of 24.32 μM. α-Glucosidase-IN-104 has a weak inhibitory effect on α-amylase and avoids gastrointestinal side effects. α-Glucosidase-IN-104 can be used for research on type 2 diabetes .

HY-175605

*α-Amylase/α-Glucosidase-IN-21*	Glycosidase Amylases	Metabolic Disease
α-Amylase/α-Glucosidase-IN-21 (Compound 4) is a dual-functional inhibitor of *α-Glucosidase* and α-Amylase with IC₅₀s of 0.27 and 0.19 µg/mL for α-Glucosidase and α-Amylase, respectively. α-Amylase/α-Glucosidase-IN-21 has an antidiabetic activity.α-Amylase/α-Glucosidase-IN-21 can be used for diabetes mellitus research .

HY-149342

α-Glucosidase-IN-29	Glycosidase	Metabolic Disease
α-Glucosidase-IN-29 (compound 19) is a α-glucosidases inhibitor (IC₅₀=1.21 μM, Ki=1.80 μM). α-Glucosidase-IN-29 ca be used for research of diabetes and related diseases .

HY-117603

CM-10-18	Glucokinase	Infection
CM-10-18 is a potent and orally active inhibitor of both α-glucosidases I and II in vitro and in animals. CM-10-18 inhibits DENV infection of cultured human cells and reduces the peak viremia of DENV in mice .

HY-145275

EB-0176	Glycosidase	Infection
EB-0176 is a potent inhibitor of *ER α-glucosidases* (α-Glu) Iand II with IC₅₀**s of 0.6439 and 0.0011 μM, respectively. EB-0176 is a N-substituted derivative of valiolamine with broad-spectrum antiviral. EB-0176 has the potential for the reseach of broad-spectrum agent against the existing and emerging viruses .

HY-145274

EB-0156	Glycosidase	Infection
EB-0156 is a potent inhibitor of *ER α-glucosidases* (α-Glu) Iand II with IC₅₀**s of 0.0479 and less than 0.001 μM, respectively. EB-0156 is a N-substituted derivative of valiolamine with broad-spectrum antiviral. EB-0156 has the potential for the reseach of broad-spectrum agent against the existing and emerging viruses .

HY-156078

α-Glucosidase-IN-32	Glycosidase	Metabolic Disease
α-Glucosidase-IN-32 (compound f26) is a reversible, noncompetitive and orally active α-glucosidase inhibitor with an IC₅₀ value of 3.07 μM. α-Glucosidase-IN-32 complex with α-glucosidase through hydrogen bonds and hydrophobic interactions, led to changes in the conformation and secondary strictures of α-glucosidase and further the inhibition of the enzymatic activity. α-Glucosidase-IN-32 can be used for diabetic disease research .

HY-157489

α-Glucosidase-IN-47	Glycosidase	Metabolic Disease
α-Glucosidase-IN-47 (compound 8H) is a non-competitive α-glucosidase (α-glucosidase) inhibitor with IC₅₀ value is 38.2 μM and K_i value is 38.2 μM. α-Glucosidase-IN-47 can be used in diabetes research. .

HY-148575

α-Glucosidase-IN-23	Glycosidase	Metabolic Disease
α-Glucosidase-IN-23 is an orally active *α-Glucosidase* inhibitor. α-Glucosidase-IN-23 decreases blood glucose by a-glucosidase inhibition with an IC₅₀ value of 4.48 μM. α-Glucosidase-IN-23 can be used for the research of diabetes .

HY-161522

α-Glucosidase-IN-63	Glycosidase Carbonic Anhydrase	Endocrinology
α-Glucosidase-IN-63 (Compound 4d) is an inhibitor of *α-Glucosidase* (IC₅₀=0.44 μM). α-Glucosidase-IN-63 inhibits hCA II with an activity of K_i= 7.0 nM. α-Glucosidase-IN-63 is orally effective. .

HY-149341

α-Glucosidase-IN-28	Glycosidase	Metabolic Disease
α-Glucosidase-IN-28 (Compound 18) is a *α-Glucosidase* inhibitor (IC₅₀: 0.62 μM, K_i: 3.93 μM). α-Glucosidase-IN-28 binds to α-glucosidase at the original binding site (OBS), and forms multiple hydrophobic interactions with nearby amino acids. α-Glucosidase-IN-28 can be used for research of diabetes and related diseases .

HY-149579

α-Glucosidase-IN-36	Glycosidase	Metabolic Disease
α-Glucosidase-IN-36 (compound 5g) is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 6.69 ± 0.18 μM, K_i and K_is of 1.65 μM and 4.54 μM, respectively. α-Glucosidase-IN-36 may inhibit α-glucosidase activity by binding with its active site as well as changing the secondary structure of α-glucosidase. α-Glucosidase-IN-36 can be used for type 2 diabetes mellitus (T2DM) research .

HY-163066

α-Glucosidase-IN-44	Glycosidase	Metabolic Disease
α-Glucosidase-IN-44 (compound IT4) is an inhibitor of *α-glucosidase* with IC₅₀ value of 2.35 μM. α-Glucosidase-IN-44 has an oral activity. α-Glucosidase-IN-44 suppresses fasting blood glucose levels in diabetic mice .

HY-161999

α-Glucosidase-IN-73	Glycosidase	Metabolic Disease Inflammation/Immunology
α-Glucosidase-IN-73 (compound 16b) is an *α-Glucosidase* inhibitor with IC₅₀ of 0.158 μM. α-Glucosidase-IN-73 can activate PPAR γ. α-Glucosidase-IN-73 can be used in anti-diabetic and anti-inflammatory studies .

HY-155372

α-Glucosidase-IN-39	Glycosidase	Metabolic Disease
α-Glucosidase-IN-39 is a potent inhibitor of α-glucosidase enzyme with an IC₅₀ of 869.06 ppm. α-Glucosidase-IN-39 can used in study antidiabetic .

HY-N11512

α-Glucosidase-IN-24	Glycosidase	Metabolic Disease
α-Glucosidase-IN-24 (Compound 13) is an *α-Glucosidase* inhibitor with an IC₅₀ of 451 μM. α-Glucosidase-IN-24 can be isolated from Swertia kouitchensis .

HY-115978

α-Glucosidase-IN-2	Glycosidase	Metabolic Disease
α-Glucosidase-IN-2 (compound 5d) is a potent *α-Glucosidase* inhibitor with an IC₅₀ of 9.48 µM. α-Glucosidase-IN-2 is an antidiabetic agent .

HY-162287

α-Glucosidase-IN-51	Glycosidase	Metabolic Disease
α-Glucosidase-IN-51 (compound 9) is an inhibitor of *α-Glucosidase* .

HY-162286

α-Glucosidase-IN-50	Glycosidase	Metabolic Disease
α-Glucosidase-IN-50 (compound 8) is an inhibitor of *α-Glucosidase* .

HY-W783267

α-Glucosidase-IN-35	Glycosidase	Metabolic Disease
α-Glucosidase-IN-35 (compound 1) is a kind of chromene. α-Glucosidase-IN-35 can be isolated from the aqueous extract of the aerial parts of Brickellia cavanillesii. α-Glucosidase-IN-35 is a potent inhibitor of *α-glucosidase* with an IC₅₀ value of 0.169 mg/mL .

HY-147823

α-Glucosidase-IN-6	Glycosidase	Metabolic Disease
α-Glucosidase-IN-6 (compound 18) is a competitive *α-glucosidase* inhibitor with an IC₅₀ of 5.69 µM. α-Glucosidase-IN-6 has anti-diabetic potential .

HY-170866

α-Glucosidase-IN-81	Glycosidase	Metabolic Disease
α-Glucosidase-IN-81 (Compound 5) is a potent *α-Glucosidase* inhibitor with an IC₅₀ value of 5.30 μM. α-Glucosidase-IN-81 is promising for research of diabetes .

HY-157488

α-Glucosidase-IN-46	Glycosidase	Metabolic Disease
α-Glucosidase-IN-46 is a potent *α-glucosidase* inhibitor with an IC₅₀ of 26.0 μM. α-Glucosidase-IN-46 can be used for the research of type 2 diabetes .

HY-161318

α-Glucosidase-IN-52	Glycosidase	Metabolic Disease
α-Glucosidase-IN-52 (Compound 3h) is an *α-glucosidase* inhibitor with an IC₅₀ of 2.8 μM. α-Glucosidase-IN-52 can be used for diabetes research .

HY-149676

α-Glucosidase-IN-42	Glycosidase	Metabolic Disease
α-Glucosidase-IN-42 (Compound 26) is a 9-O-berberrubine carboxylate derivative. α-Glucosidase-IN-42 has potent α-glucosidase inhibitory activities with an IC₅₀ value in the range of 1.61 μM. α-Glucosidase-IN-42 can be used for the research of antidiabetic .

HY-149668

α-Glucosidase-IN-41	Glycosidase	Metabolic Disease
α-Glucosidase-IN-41 (compound 5o) is a potent *α-glucosidase* inhibitor. α-Glucosidase-IN-41 can arise the changed secondary structure of α-Glu to hinder enzyme catalytic activity. α-Glucosidase-IN-41 can be used for diabetes mellitus research .

HY-161764

α-Glucosidase-IN-67	Amylases Glycosidase	Metabolic Disease
α-Glucosidase-IN-67 (compound 5k) is a potent *α-Glucosidase* inhibitor with IC₅₀ values of 0.31, 4.51 µM for alpha-glucosidase and alpha-amylase, respectively. α-Glucosidase-IN-67 has the potential for the research of type-2 diabetes .

HY-147718

α-Glucosidase-IN-5	Glutaminase	Metabolic Disease
α-Glucosidase-IN-5 (compound 8) is a potent *α-glucosidase* inhibitor with an IC₅₀ of 57.9 µM. α-Glucosidase-IN-5 has the potential for the research of diabetes mellitus .

HY-151142

α-Glucosidase-IN-18	Glycosidase	Metabolic Disease
α-Glucosidase-IN-18 (7B) is an orally active *α-glucosidase* inhibitor with an IC₅₀ value of 3.96 μM. α-Glucosidase-IN-18 has antidiabetic activity .

HY-151141

α-Glucosidase-IN-17	Glycosidase	Metabolic Disease
α-Glucosidase-IN-17 (Compound 12B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.79 μM. α-Glucosidase-IN-17 shows antidiabetic activity .

HY-147964

α-Glucosidase-IN-9	Glycosidase	Metabolic Disease
α-Glucosidase-IN-9 (compound 7) is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 55.6 μM. α-Glucosidase-IN-9 can be used for type II diabetes research .

HY-151135

α-Glucosidase-IN-15	Glycosidase	Metabolic Disease
α-Glucosidase-IN-15 (Compound 14B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.34 μM. α-Glucosidase-IN-15 shows antidiabetic activity .

HY-147965

α-Glucosidase-IN-10	Glycosidase	Metabolic Disease
α-Glucosidase-IN-10 (compound 13) is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 92.7 μM. α-Glucosidase-IN-10 can be used for type II diabetes research .

HY-151143

α-Glucosidase-IN-19	Glycosidase	Metabolic Disease
α-Glucosidase-IN-19 (Compound 6B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.63 μM. α-Glucosidase-IN-19 shows anti-diabetic activity .

HY-157311

α-Glucosidase-IN-45	Glycosidase	Cancer
α-Glucosidase-IN-45 (compound 11E) is an inhibitor of *α-glucosidase. α-Glucosidase*-IN-45 is a novel indol-fused pyrano[2,3-D]pyrimidine compound .

HY-N12664

α-Glucosidase-IN-54	Glycosidase	Metabolic Disease
α-Glucosidase-IN-54 (compound 2) is a *α-glucosidase* inhibitor with the IC₅₀ of 0.011 mM, and can be isolated form Syzygium jambos (L.). α-Glucosidase-IN-54 can be used for study of diabetes .

HY-158697

α-Glucosidase-IN-65	Glycosidase	Metabolic Disease
α-Glucosidase-IN-65 (compound 5) is a Schiff base derivative of 3,4-dihydroxyphenylacetic acid. α-Glucosidase-IN-65 is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 12.84 μM .

HY-151145

α-Glucosidase-IN-21	Glycosidase	Metabolic Disease
α-Glucosidase-IN-21 (Compound 2B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 2.62 μM. α-Glucosidase-IN-21 shows anti-diabetic activity .

HY-151144

α-Glucosidase-IN-20	Glycosidase	Metabolic Disease
α-Glucosidase-IN-20 (Compound 3B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.01 μM. α-Glucosidase-IN-20 shows anti-diabetic activity .

HY-175170

α-Glucosidase-IN-95	Glycosidase	Metabolic Disease
α-Glucosidase-IN-95 (Compound 21c) is a competitive *α-Glucosidase* inhibitor with an IC₅₀ of 0.44  μM. α-Glucosidase-IN-95 has a significant inhibitory potency without cytotoxicity to normal cells. α-Glucosidase-IN-95 can be used for metabolic disorders like diabetes mellitus research .

HY-146225

*α-Amylase/α-Glucosidase-IN-2*	Glycosidase	Metabolic Disease
α-Amylase/α-Glucosidase-IN-2 (compound 5) is a potent α-amylase and *α-glucosidase* dual inhibitor with IC₅₀ values of 13.02, 13.09 µM for α-amylase and α-glucosidase, respectively. α-Amylase/α-Glucosidase-IN-2 has the potential for the research of diabetic complications .

HY-N12689

α-Glucosidase-IN-56	Glycosidase	Metabolic Disease
α-Glucosidase-IN-56 (compound 1) is an orally active, potent *α‐glucosidase* inhibitor with an IC₅₀ value of 45.86 μM. α-Glucosidase-IN-56 has potent anti-glycation activities .

Cat. No.	Product Name	Type

HY-78000

Methyl 4-formylbenzoate 4-Carbomethoxybenzaldehyde; 4-Carboxybenzaldehyde methyl ester; Terephthalaldehydic acid methyl ester; Methyl 4-formylbenzoate	Biochemical Assay Reagents
Methyl 4-formylbenzoate (4-Carbomethoxybenzaldehyde; 4-Carboxybenzaldehyde methyl ester; Terephthalaldehydic acid methyl ester; Methyl 4-formylbenzoate) is a intermediate that can be used for the synthesis of chalcone amide α-glucosidase inhibitors .

HY-W005598

2-Hydroxyquinoline	Biochemical Assay Reagents
2-Hydroxyquinoline is an inhibitor of *α-glucosidase* and α-amylase with IC₅₀ values of 64.4 µg/mL and 130.5 µg/mL, respectively. 2-Hydroxyquinoline can be used in the study of diabetes .

HY-E70183

Lysosomal α-Glucosidase EC:3.2.1.20; GAA	Biochemical Assay Reagents
Lysosomal α-Glucosidase (EC:3.2.1.20) is a γ-amylase with specificity for glycogen and several natural and synthetic oligoglucosides .

HY-N2024B

Maltose solution, 20% in H2O

Biochemical Assay Reagents

Maltose solution, 20% in H₂O is a 20% aqueous maltose solution. Maltose is a disaccharide composed of two glucose molecules linked together. Maltose is an endogenous metabolic product in plants, yeast, or bacteria, and it participates in carbon source storage and metabolism. Maltose is a key core metabolite and main transport form in the temporary starch degradation, carbon output, and subsequent sucrose synthesis metabolism of the night chloroplast. In X. dendrorhous, maltose can act as a sugar donor and is converted into isomaltulose by α-glucosidase. Maltose can act as a osmotic agent, supporting continuous capillary ultrafiltration and preventing severe metabolic disorders .

HY-123115

Leucrose

5-O-α-D-Glucopyranosyl-D-fructose

Biochemical Assay Reagents

Leucrose (5-O-α-D-Glucopyranosyl-D-fructose) is an orally active Sucrose (HY-B1779) isomer naturally found in pollen and honey. Leucrose promotes phosphorylation of JAK1 and STAT6, reduces pro-inflammatory mediators and cytokinesas (TNFα, and IL-1β), increases M2 macrophage polarization and suppresses DSS (HY-116282C)-induced colitis. Leucrose suppresses hepatic triglyceride accumulation, improves fasting blood glucose levels, and regulates hepatic lipogenesis and fatty acid β-oxidation in high-fat diet-induced obese mice. Leucrose is slowly hydrolyzed into glucose and fructose by α-glucosidase and acts as as a sugar substitute in diet .

HY-W826489

D-Glucopyranose, 98% α-Sophorose, 98%	Biochemical Assay Reagents
D-Glucopyranose, 98% serves as a substrate for various glycosidase enzymes, including α-glucosidase, and is also used in glycobiology research.

HY-78000R

Methyl 4-formylbenzoate (Standard) 4-Carbomethoxybenzaldehyde (Standard); 4-Carboxybenzaldehyde methyl ester (Standard); Terephthalaldehydic acid methyl ester (Standard); Methyl 4-formylbenzoate (Standard)	Biochemical Assay Reagents
Methyl 4-formylbenzoate (4-Carbomethoxybenzaldehyde) (Standard) is the analytical standard of Methyl 4-formylbenzoate (HY-78000). This product is intended for research and analytical applications. Methyl 4-formylbenzoate is a drug intermediate that can be used to synthesis chalcone amide α-glucosidase inhibitors .

Cat. No.	Product Name	Target	Research Area

HY-101399R

γ-Glu-Phe (Standard) H-γ-Glu-Phe-OH (Standard); γ-Glutamylphenylalanine (Standard)	Reference Standards Endogenous Metabolite	Others
Ceftezole (sodium) (Standard) is the analytical standard of Ceftezole (sodium). This product is intended for research and analytical applications. Ceftezole sodium (CTZ sodium) is a broad-spectrum cephem antibiotic against many species of gram-positive and gram-negative bacteria. Ceftezole sodium (CTZ sodium) is an alpha-glucosidase inhibitor with in vivo anti-diabetic activity .

Cat. No.	Product Name	Target	Research Area	Image

HY-P99803

Clervonafusp alfa VAL-1221	Glycosidase	Others
Clervonafusp alfa (VAL-1221) is a fusion protein targeting both cytosolic and lysosomal glycogen. Clervonafusp alfa is comprised of the Fab portion of a cell-penetrating antibody and recombinant human acid alpha glucosidase (rhGAA), the former utilizing the nucleoside transporter ENT-2 to gain access to the cytosol, and the latter enters lysosomes via mannose-6-phosphate receptors (M6PRs). Clervonafusp alfa can be used for late-onset Pompe disease research .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-132179

Fucoidan 5+ Cited Publications	Brown seaweed Classification of Application Fields Marine natural products Whitening Agent Metabolic Disease Plants Polysaccharides other families Marine algae Cosmetic Research Disease Research Fields Saccharides Source Classification Cancer	Glycosidase
Fucoidan, a biologically active polysaccharide, is an efficient inhibitor of α-amylase and α-glucosidase. Anticoagulant, antitumor, antioxidant and antisteatotic activities .

HY-B0089

Acarbose 5+ Cited Publications BAY g 5421	Structural Classification Polysaccharides Microorganisms Classification of Application Fields Anti-aging Metabolic Disease Disease Research Fields Saccharides Source Classification	Glycosidase
Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active *alpha-glucosidase* inhibitor (IC₅₀=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin .

HY-14860

1-Deoxynojirimycin 5+ Cited Publications Duvoglustat	Alkaloids Piperidine Alkaloids Classification of Application Fields Metabolic Disease Plants Moraceae Disease Research Fields Morus alba Linn. Source Classification	Glycosidase PI3K
1-Deoxynojirimycin (Duvoglustat) is a potent and orally active *α-glucosidase* inhibitor. 1-Deoxynojirimycin suppresses postprandial blood glucose and is widely used for diabetes mellitus. 1-Deoxynojirimycin possesses antihyperglycemic, anti-obesity, and antiviral features .

HY-14860A

1-Deoxynojirimycin hydrochloride 5+ Cited Publications Duvoglustat hydrochloride	Commelinaceae Classification of Application Fields Commelina communis L. Metabolic Disease Plants Disease Research Fields Saccharides Monosaccharides Source Classification	Glycosidase PI3K Bacterial Antibiotic
1-Deoxynojirimycin hydrochloride (Duvoglustat hydrochloride) is a potent and orally active *α-glucosidase* inhibitor. 1-Deoxynojirimycin hydrochloride suppresses postprandial blood glucose and is widely used for diabetes mellitus. 1-Deoxynojirimycin hydrochloride possesses antihyperglycemic, anti-obesity, and antiviral features .

HY-N0464

D-(-)-Quinic acid 3 Publications Verification	Infection Microorganisms other families Classification of Application Fields Ketones, Aldehydes, Acids Plants Endogenous metabolite Disease Research Fields Source Classification	Endogenous Metabolite Glycosidase Monoamine Oxidase
D-(-)-Quinic acid scavenges hydrogen peroxide (IC₅₀=87.11 μg/mL) and exhibits antioxidant activity. D-(-)-Quinic acid is the inhibitor for MAO and *α-Glucosidase* (IC₅₀ =93.75 μg/mL). D-(-)-Quinic acid is orally active .

HY-N0419

Quercimeritrin 2 Publications Verification Quercetin-7-O-β-D-glucopyranoside	Flavonols Structural Classification Ginkgoaceae Classification of Application Fields Metabolic Disease Plants Compositae Endogenous metabolite Ginkgo biloba Human Gut Microbiota Metabolites Flavonoids Derris scandens Disease Research Fields Source Classification	Glycosidase c-Kit MMP VEGFR Aurora Kinase
Quercimeritrin (Quercetin-7-O-β-D-glucopyranoside) is an orally active *α-glucosidase* inhibitor (with an IC₅₀ of 79.88 μM against the Saccharomyces cerevisiae enzyme) and a P-gp substrate, with anti-angiogenic and antioxidant activities. Quercimeritrin does not cross the blood-brain barrier and does not inhibit cytochrome P450 enzymes. Quercimeritrin precisely binds to and inhibits the active sites of c-Kit, MMP-2, Aurora-A kinases and α-glucosidase, thereby disrupting target functions. Quercimeritrin effectively regulates postprandial blood glucose and also exhibits significant anti-angiogenic activity, which inhibits endothelial cell proliferation and microvascular growth. Quercimeritrin can be used in the research of diabetes and breast cancer .

HY-N0374

Licochalcone C 4 Publications Verification	Chalcones Flavonoids Classification of Application Fields Leguminosae Metabolic Disease Plants Glycyrrhiza uralensis Fisch. Disease Research Fields Source Classification	Glycosidase
Licochalcone C could inhibit *α-glucosidase, with IC₅₀s* of <100 nM and 92.43 μM for α-glucosidase and protein tyrosine phosphatase 1B (PTP1B), respectively.

HY-N6675

Gardenia yellow	Structural Classification Natural Products Neurological Disease Classification of Application Fields Lridaceae Plants Crocus sativus L. Disease Research Fields Source Classification Cancer	Amylases Glycosidase
Gardenia yellow is a competitive inhibitor of α-Amylase (HY-B2193) and *α-glucosidase. Gardenia yellow can bind to the catalytic sites of α-Amylase* and α-glucosidase, inhibit starch digestion, and significantly increase the contents of resistant starch and slowly digestible starch in starch-based systems. Gardenia yellow reduces the glycemic index and hydrolysis index. Gardenia yellow can be used in diabetes-related research .

HY-N4195

Resveratroloside 2 Publications Verification Resveratrol glycoside; trans-Resveratrol 4'-O-β-D-glucopyranoside	Cardiovascular Disease Stilbenes Classification of Application Fields Polygonaceae Reynoutria japonica Houtt. Phenols Polyphenols Plants Disease Research Fields Source Classification	Glycosidase
Resveratroloside (Resveratrol glycoside) is an orally active competitive inhibitor of *α-glucosidase*. Resveratroloside has hypoglycemic and cardioprotective effects. Resveratroloside can be used for the research of diabetes and heart system diseases .

HY-125713

Ganoderic acid Y	Infection Triterpenes Classification of Application Fields Terpenoids Polyporaceae Plants Disease Research Fields Source Classification	Glycosidase Enterovirus
Ganoderic acid Y is a *α-glucosidase* inhibitor with an IC₅₀ of 170 μM for yeast α-glucosidase. Ganoderic acid Y inhibits enterovirus 71 (EV71) replication through blocking EV71 uncoating .

HY-W009417

Cedryl acetate	Structural Classification Classification of Application Fields Terpenoids Sesquiterpenes Taxodiaceae Metabolic Disease Plants Cunninghamia lanceolata var. konishii Disease Research Fields Source Classification	Environmental Pollutants Glycosidase
Cedryl acetate is an orally active *α-glucosidase* inhibitor with an IC₅₀ of 94 μM against yeast α-glucosidase. Cedryl acetate reduces high-fat diet-induced body weight gain, visceral fat pad weight, adipocyte hypertrophy, hepatic lipid accumulation, glucose intolerance, insulin resistance and gluconeogenesis. Cedryl acetate can be used in the research of obesity and obesity-related metabolic syndrome .

HY-126067

(-)-Pinoresinol	Structural Classification other families Hernandia nymphaeifolia (C. Presl) Kubitzki Lignans Phenylpropanoids Plants Source Classification	Glycosidase Apoptosis
(-)-Pinoresinol is a plant-derived tetrahydrofuran lignan that inhibits *α-glucosidase* and acts as a hypoglycemic agent. (-)-Pinoresinol has some anti-inflammatory effects and acts as a chemopreventive agent, inducing increased apoptosis and cell cycle G2/M arrest .

HY-N4258

Panasenoside	Panax ginseng C. A. Meyer Flavonols Classification of Application Fields Metabolic Disease Plants Lilium pumilum DC. Flavonoids Liliaceae Phenols Polyphenols Disease Research Fields Araliaceae Source Classification	Glycosidase
Panasenoside is a flavonoid isolated from Lilium pumilum DC. Panasenoside exhibits *α-glucosidase* inhibitory activity .

HY-N9317

Tangshenoside I	Classification of Application Fields Ketones, Aldehydes, Acids Campanulaceae Metabolic Disease Codonopsis lanceolata (Sieb. et Zucc.) Trautv. Plants Disease Research Fields Source Classification	Glycosidase
Tangshenoside I, isolated from the roots of Codonopsis lanceolata, exhibits weak α-glucosidase inhibitory activities in vitro with an IC₅₀ of 1.4 mM .

HY-N7203

N-Caffeoyl O-methyltyramine	Alkaloids Classification of Application Fields Other Alkaloids Phenols Polyphenols Metabolic Disease Plants Annonaceae Disease Research Fields Source Classification Fissistigma oldhamii (Hemsl.) Merr.	Glycosidase
N-Caffeoyl O-methyltyramine is a class of alkaloid isolated from Cuscuta reflexa with strong inhibitory activity against *α-glucosidase* (IC₅₀ of 103.58 μM) .

HY-N2821

(+)-Afzelechin 4 Publications Verification	Flavonoids Classification of Application Fields Flavanols Phenols Polyphenols Metabolic Disease Plants Saxifragaceae Disease Research Fields Source Classification	Glycosidase
(+)-Afzelechin, isolated from rhizomes of Bergenia ligulata, is an *alpha-glucosidase* activity inhibitor with an ID₅₀ (50% inhibition dose) value of 0.13 mM. (+)-Afzelechin can delay the absorption of carbohydrates in food to suppress postprandial hyperglycemia and hyperinsulinemia .

HY-N2024R

Maltose (Standard)	Structural Classification Polysaccharides Endogenous metabolite Saccharides Source Classification	Reference Standards Endogenous Metabolite Glycosidase
Maltose (Standard) is the analytical standard of Maltose. This product is intended for research and analytical applications. Maltose is a disaccharide composed of two glucose molecules linked together. Maltose is an endogenous metabolic product in plants, yeast, or bacteria, and it participates in carbon source storage and metabolism. Maltose is a key core metabolite and main transport form in the temporary starch degradation, carbon output, and subsequent sucrose synthesis metabolism of the night chloroplast. In X. dendrorhous, maltose can act as a sugar donor and is converted into isomaltulose by α-glucosidase (α-Glucosidase). Maltose can act as a osmotic agent, supporting continuous capillary ultrafiltration and preventing severe metabolic disorders.

HY-N7377

Butyl isobutyl phthalate	Natural Products other families Classification of Application Fields Metabolic Disease Plants Disease Research Fields Source Classification	Glycosidase
Butyl isobutyl phthalate is isolated from the rhizoid of Laminaria japonica. Butyl isobutyl phthalate is a non-competitive *α-glucosidase* inhibitor with an IC₅₀ value of 38 μM. Butyl isobutyl phthalate shows a hypoglycemic effect and has the potential for diabetes treatment .

HY-N7683

Prunetin 5-O-β-D-glucopyranoside	Structural Classification Monophenols Flavonoids Classification of Application Fields Rosaceae Phenols Metabolic Disease Plants Prunus avium Disease Research Fields Isoflavones Source Classification	Glycosidase
Prunetin 5-O-β-D-glucopyranoside is an isoflavone. Prunetin 5-O-β-D-glucopyranoside can be isolated from the pedicels of Prunus avium and Prunus cerasus. Prunetin 5-O-β-D-glucopyranoside acts as a non-competitive *α-glucosidase* inhibitor, with a IC₅₀ of 56.05 μg/mL and a K_i of 121 μg/mL against Saccharomyces cerevisiae α-glucosidase. Prunetin 5-O-β-D-glucopyranoside can be used in studies related to type 2 diabetes .

HY-B0089R

Acarbose (Standard) BAY g 5421 (Standard)	Structural Classification Polysaccharides Microorganisms Saccharides Source Classification	Reference Standards Glycosidase
Acarbose (Standard) is the analytical standard of Acarbose. This product is intended for research and analytical applications. Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin .

HY-119821

Terphenyllin	Infection Microorganisms Classification of Application Fields Phenols Polyphenols Disease Research Fields Source Classification	Glycosidase
Terphenyllin is a naturally abundant p-terphenyl metabolite isolated from the coral derived fungus Aspergillus candidus, has signiﬁcant *α-glucosidase* inhibitory activity .

HY-200541

Dihydro-α-ionone	Structural Classification Ketones, Aldehydes, Acids Aucklandia costus Falc. Asteraceae Plants Source Classification	Others
Dihydro-α-ionone is a volatile compound found in the essential oil of Persicaria hydropiper L. leaves. The essential oil can inhibit α-glucosidase and α-amylase activities .

HY-N10002

Caffeoyltryptophan 1 Publications Verification	Ketones, Aldehydes, Acids Coffea canephora Pierre ex Froehn. Rubiaceae Phenols Polyphenols Plants Source Classification	Phosphatase Glycosidase
Caffeoyltryptophan is a competitive PTP1B inhibitor, with an IC₅₀ of 16.99 μM. Caffeoyltryptophan can also inhibit *α-glucosidase*, linoleic acid peroxidation and haemolysis. Caffeoyltryptophan can be used for the research of type 2 diabetes .

HY-N8517

Malabaricone B	Infection Classification of Application Fields Ketones, Aldehydes, Acids Phenols Polyphenols Metabolic Disease Myristicaceae Plants Myristica fragrans Houtt. Disease Research Fields Cancer Source Classification	Glycosidase Apoptosis
Malabaricone B, a naturally occurring plant phenolic, is an orally active *α-glucosidase* inhibitor with an IC₅₀ of 63.7 µM. Malabaricone B has anticancer, antimicrobial, anti-oxidation and antidiabetic activities .

HY-N16575

16-Oxoserratenediol	Lycopodiaceae Triterpenes Structural Classification Terpenoids Palhinhaea cernua (L.) Vasc. et Franco Plants Source Classification	Glycosidase
16-Oxoserratenediol (Compound 11) is a serratene-type triterpenoid found in Lycopodium cernuum L.. 16-Oxoserratenediol is a *α-glucosidase* inhibitor with inhibition rate of 43.93% at 100 μM. 16-Oxoserratenediol can be used for the research of diabetes .

HY-N3542

Carpachromene	Flavonoids Flavones Plants Calophyllaceae Calophyllum symingtonianum M.R.Hend. & Wyatt-Sm. Source Classification	Glycosidase
Carpachromene is a potent α-glucosidase enzyme inhibitor. Carpachromene ameliorates insulin resistance in HepG2 cells via modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 pathway .

HY-N2223

Ganoderol B Ganodermadiol	Triterpenes Classification of Application Fields Terpenoids Polyporaceae Metabolic Disease Ganoderma lucidum (Leyss. Ex Fr.) Karst. Plants Disease Research Fields Source Classification	Glycosidase
Ganoderol B is a potent *α-glucosidase* inhibitor. Ganoderol B has high α-glucosidase inhibition with an IC₅₀ of 48.5 μg/mL (119.8 μM) .

HY-N3962

Glycyrrhisoflavone	Flavonoids Classification of Application Fields Leguminosae Phenols Polyphenols Metabolic Disease Plants Disease Research Fields Glycyrrhiza uralensis Fisch. Isoflavones Source Classification	Glycosidase
Glycyrrhisoflavone, an active prenylflavonoid, inhibits *α-glucosidase* .

HY-N3101

Pedalitin 2 Publications Verification	Flavonoids other families Classification of Application Fields Flavones Phenols Polyphenols Plants Disease Research Fields Endocrinology Source Classification	Endogenous Metabolite Tyrosinase Glycosidase
Pedalitin is a inhibitor of tyrosinase（IC₅₀=0.28 mM） and α-glucosidase（IC₅₀=0.29 mM） .

HY-129131

Chrysin 6-C-arabinoside 8-C-glucoside	Flavonoids Rheum palmatum L. Flavones Polygonaceae Plants Source Classification	Glycosidase
Chrysin 6-C-arabinoside 8-C-glucoside is a α±-glucosidase inhibitors which are widely used in the study for type 2 diabetes .

HY-N1218

Stellasterol	Structural Classification Animals Steroids Source Classification	Glycosidase Bcl-2 Family
Stellasterol is a natural product. Stellasterol has high affinity towards Bcl-2 protein (K_i: 118.05 nM). Stellasterol is a weak α-glucosidase inhibitor .

HY-N10413

Diphlorethohydroxycarmalol	other families Classification of Application Fields Phenols Polyphenols Metabolic Disease Plants Disease Research Fields Source Classification Ishige okamurae	Glycosidase
Diphlorethohydroxycarmalol, a kind of phlorotannin, is an orally active *α-glucosidase* and α-amylase inhibitor with IC₅₀s of 0.16 mM and 0.53 mM, respectively. Diphlorethohydroxycarmalol has anti-diabetic activities .

HY-101399R

γ-Glu-Phe (Standard) H-γ-Glu-Phe-OH (Standard); γ-Glutamylphenylalanine (Standard)	Structural Classification Microorganisms Ketones, Aldehydes, Acids Endogenous metabolite Source Classification	Reference Standards Endogenous Metabolite
Ceftezole (sodium) (Standard) is the analytical standard of Ceftezole (sodium). This product is intended for research and analytical applications. Ceftezole sodium (CTZ sodium) is a broad-spectrum cephem antibiotic against many species of gram-positive and gram-negative bacteria. Ceftezole sodium (CTZ sodium) is an alpha-glucosidase inhibitor with in vivo anti-diabetic activity .

HY-W127945

N-(E)-Caffeoyldopamine	Labiatae Phenols Polyphenols Plants Swartzia polyphylla DC. Source Classification	Glycosidase
N-(E)-Caffeoyldopamine is an inhibitor of *α-glucosidase* that can be purified from Clerodendranthus Spicatus. N-(E)-Caffeoyldopamine shows a 53.73% inhibitory activity againstα-glucosidase. N-(E)-Caffeoyldopamine can be studied in diabetes research .

HY-N3503

Ganoderlactone D	Triterpenes Classification of Application Fields Terpenoids Polyporaceae Plants Disease Research Fields Endocrinology Source Classification	Glycosidase
Ganoderlactone D shows inhibitory effects of yeast α-Glucosidase with IC₅₀ values of 41.7 μM .

HY-N10426

(+)-Cembrene A	Structural Classification Animals Terpenoids Source Classification	Glycosidase
(+)-Cembrene A (Compound 5) is a *α-glucosidase* inhibitor with an IC₅₀ of 30.31 μM. (+)-Cembrene A is nontoxic towards human normal hepatocyte (LO2) cells .

HY-N10076

Ganomycin I	Microorganisms Phenols Polyphenols Source Classification	HMG-CoA Reductase (HMGCR) Glycosidase HIV Protease
Ganomycin I is a dual inhibitor of *α-Glucosidase* and HMG-CoA reductase. Ganomycin I can also inhibits HIV protease. Ganomycin I exhibits anti-diabetic and anti-osteoclastogenesis effects .

HY-N7763

Casuarictin	Lythraceae Trapa natans L. Phenols Polyphenols Plants Source Classification	Glycosidase
Casuarictin is a potent and competitive *α-glucosidase* inhibitor with an IC₅₀ of 0.21 μg/mL. Casuarictin is a presenilin stabilization factor like protein (PSFL) protein inhibitor. Casuarictin can be used for Alzheimer's disease research .

HY-N3078

p-Hydroxyphenethyl trans-ferulate	Classification of Application Fields Simple Phenylpropanols Phenols Polyphenols Phenylpropanoids Umbelliferae Plants Disease Research Fields Echinacea angustifolia DC. Endocrinology Source Classification	Glycosidase
p-Hydroxyphenethyl trans-ferulate has anti-hyperglycemic (yeast *α-glucosidase, IC₅₀*=19.24 ± 1.73 µM), antioxidant, and anti-inflammatory activities . p-Hydroxyphenethyl trans-ferulate shows inhibiting anticancer and serotonergic activity .

HY-N11512

α-Glucosidase-IN-24	Structural Classification Xanthones Gentianaceae Phenols Plants Swertia kouitchensis Franch. Source Classification	Glycosidase
α-Glucosidase-IN-24 (Compound 13) is an *α-Glucosidase* inhibitor with an IC₅₀ of 451 μM. α-Glucosidase-IN-24 can be isolated from Swertia kouitchensis .

HY-W783267

α-Glucosidase-IN-35	Natural Products Plants Compositae Brickellia cavanillesii A.Gray Source Classification	Glycosidase
α-Glucosidase-IN-35 (compound 1) is a kind of chromene. α-Glucosidase-IN-35 can be isolated from the aqueous extract of the aerial parts of Brickellia cavanillesii. α-Glucosidase-IN-35 is a potent inhibitor of *α-glucosidase* with an IC₅₀ value of 0.169 mg/mL .

HY-N12664

α-Glucosidase-IN-54	Ketones, Aldehydes, Acids Myrtaceae Plants Syzygium jambos (L.) Alston Source Classification	Glycosidase
α-Glucosidase-IN-54 (compound 2) is a *α-glucosidase* inhibitor with the IC₅₀ of 0.011 mM, and can be isolated form Syzygium jambos (L.). α-Glucosidase-IN-54 can be used for study of diabetes .

HY-N12689

α-Glucosidase-IN-56	Pistacia chinensis Bunge Phenols Polyphenols Plants Anacardiaceae Source Classification	Glycosidase
α-Glucosidase-IN-56 (compound 1) is an orally active, potent *α‐glucosidase* inhibitor with an IC₅₀ value of 45.86 μM. α-Glucosidase-IN-56 has potent anti-glycation activities .

HY-162541

α-Glucosidase-IN-64	Natural Products Hypericaceae Hypericum beanii N. Robson Plants Source Classification	Glycosidase
α-Glucosidase-IN-64 (compound 10) is a potent *α-glucosidase* inhibitor with an IC₅₀ value of 8.62 µM. α-Glucosidase-IN-64 is a polycyclic polyprenylated acylphloroglucinol that can be isolated from hypericum beanii .

HY-N12347

α-Glucosidase-IN-37	Ketones, Aldehydes, Acids Amomum villosum Lour. Plants Source Classification Zingiberaceae	Others
α-Glucosidase-IN-37 (Compound 11) moderately inhibits LPS-induced NO production with an IC₅₀ value of 23.7 μM in macrophages. α-Glucosidase-IN-37 has weak inhibitory activity against α-Glucosidase .

HY-N13173

α-Glucosidase-IN-70	Quinones Anthraquinones Gentianaceae Swertia mussotii Franch. Plants Source Classification	Glycosidase
α-Glucosidase-IN-70 (compound 9) is an α-glucosidase inhibitor (IC₅₀=31.1 μM) isolated from the traditional Chinese herbal medicine Swertia mussotii. α-Glucosidase-IN-70 can be used in the research of diabetes .

HY-N8120

Bisabolone oxide A	Natural Products other families Classification of Application Fields Metabolic Disease Plants Disease Research Fields Source Classification	Glycosidase
Bisabolone oxide A is an *α-glucosidase* inhibitor .

HY-119593

α-Homonojirimycin Homonojirimycin	Natural Products Omphalea diandra Vell. Euphorbiaceae Plants Source Classification	Glycosidase
α-Homonojirimycin is a potent *α-glucosidase* inhibitor .

HY-N15138

Sativanone	Flavonoids Dalbergia tonkinensis Prain Leguminosae Isoflavanones Plants Source Classification	Glycosidase
Sativanone is a compound that can be isolated from Dalbergia tonkinensis. Sativanone is a potent *α-glucosidase* inhibitor, with an EC₅₀ of 0.357 mg/mL for rat α-glucosidase. Sativanone has antibacterial activity against Ralstonia solanacearum. Sativanone also has anti-senescent and antioxidant effects .

HY-N1901

(E)-p-Coumaramide	Monophenols Portulacaceae Allium fistulosum L. Phenols Portulaca oleracea Linn. Plants Amaryllidaceae Source Classification	Glycosidase
(E)-p-Coumaramide is an *α-Glucosidase* inhibitor that can be isolated from Welsh onion .

Cat. No.	Product Name	Chemical Structure

HY-N2024AS1

Maltose-13C12 monohydrate

Maltose monohydrate- ¹³C₁₂ is the ¹³C labeled isotope of Maltose monohydrate. Maltose monohydrate is a disaccharide composed of two glucose molecules linked together. Maltose monohydrate is an endogenous metabolic product in plants, yeast, or bacteria, and it participates in carbon source storage and metabolism. Maltose monohydrate is a key core metabolite and main transport form in the temporary starch degradation, carbon output, and subsequent sucrose synthesis metabolism of the night chloroplast. In X. dendrorhous, maltose can act as a sugar donor and is converted into isomaltulose by α-glucosidase. Maltose monohydrate can act as a osmotic agent, supporting continuous capillary ultrafiltration and preventing severe metabolic disorders.

HY-N2024AS

Maltose monohydrate-d14

Maltose monohydrate-d₁₄ is the deuterium labeled Maltose monohydrate. Maltose monohydrate is a disaccharide composed of two glucose molecules linked together. Maltose monohydrate is an endogenous metabolic product in plants, yeast, or bacteria, and it participates in carbon source storage and metabolism. Maltose monohydrate is a key core metabolite and main transport form in the temporary starch degradation, carbon output, and subsequent sucrose synthesis metabolism of the night chloroplast. In X. dendrorhous, maltose can act as a sugar donor and is converted into isomaltulose by α-glucosidase. Maltose monohydrate can act as a osmotic agent, supporting continuous capillary ultrafiltration and preventing severe metabolic disorders.

HY-N0464S

Quinic acid-13C3
Quinic acid- ¹³C₃ is the ¹³C-labeled D-(-)-Quinic acid. D-(-)-Quinic acid scavenges hydrogen peroxide (IC₅₀=87.11 μg/mL) and exhibits antioxidant activity. D-(-)-Quinic acid is the inhibitor for MAO and *α-Glucosidase* (IC₅₀ =93.75 μg/mL). D-(-)-Quinic acid is orally active .

HY-B0089S

Acarbose-d4
Acarbose-d₄ (BAY g 5421-d₄) is deuterium labeled Acarbose. Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active *alpha-glucosidase* inhibitor (IC₅₀=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin .

HY-N2024AS2

Maltose monohydrate-13C

Maltose monohydrate- ¹³C is the ¹³C labeled isotope of Maltose monohydrate. Maltose monohydrate is a disaccharide composed of two glucose molecules linked together. Maltose monohydrate is an endogenous metabolic product in plants, yeast, or bacteria, and it participates in carbon source storage and metabolism. Maltose monohydrate is a key core metabolite and main transport form in the temporary starch degradation, carbon output, and subsequent sucrose synthesis metabolism of the night chloroplast. In X. dendrorhous, maltose can act as a sugar donor and is converted into isomaltulose by α-glucosidase. Maltose monohydrate can act as a osmotic agent, supporting continuous capillary ultrafiltration and preventing severe metabolic disorders.

HY-W749516

Voglibose-13C3
Voglibose- ¹³C₃ is the ¹³C-labeled Voglibose (HY-B0025). Voglibose is an orally active alpha-glucosidase inhibitor that prevents the development of colorectal precancerous lesions induced by obesity and diabetes. Voglibose reduces oxidative stress in an inflammatory environment and inhibits the insulin-like growth factor/insulin-like growth factor-1 receptor (IGF/IGF-1R) functional axis.

Cat. No.	Product Name		Classification

HY-145273

EB-0150		Azide
EB-0150 is a potent inhibitor of *ER α-glucosidases* (α-Glu) Iand II with IC₅₀**s of 0.73 and 0.0337 μM, respectively. EB-0150 is a N-substituted derivative of valiolamine with broad-spectrum antiviral. EB-0150 has the potential for the reseach of broad-spectrum agent against the existing and emerging viruses . EB-0150 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.

Cat. No.	Product Name		Classification

HY-N2024

Maltose 1 Publications Verification		Sweetening Agents
Maltose is a disaccharide composed of two glucose molecules linked together. Maltose is an endogenous metabolic product in plants, yeast, or bacteria, and it participates in carbon source storage and metabolism. Maltose is a key core metabolite and main transport form in the temporary starch degradation, carbon output, and subsequent sucrose synthesis metabolism of the night chloroplast. In X. dendrorhous, maltose can act as a sugar donor and is converted into isomaltulose by *α-glucosidase*). Maltose can act as a osmotic agent, supporting continuous capillary ultrafiltration and preventing severe metabolic disorders .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

α-glucosidases

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

NaturalProducts

Isotope-Labeled Compounds

Click Chemistry

Oligonucleotides

Natural
Products